Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Blood|September 17, 2021
Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host diseaseDivya Subburaj, Bernard Ng, Amina Kariminia, et al.
Blood|May 3, 2019
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoffrey D E Cuvelier, Eneida R Nemecek, Justin T Wahlstrom, et al.
Blood|February 13, 2020
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studiesKirk R Schultz, Amina Kariminia, Bernard Ng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2017
Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for ProphylaxisMuna Qayed, Tao Wang, Michael T Hemmer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2019
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell TransplantationBetty K Hamilton, Ying Liu, Michael T Hemmer, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 studyJakob Wirbel, Wael Saber, Michael J Martens, et al.
The Lancet. Child & Adolescent Health|December 13, 2021
Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statementMatteo Di Nardo, Ali H Ahmad, Pietro Merli, et al.
Nature Reviews. Clinical Oncology|February 20, 2021
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancerDristhi Ragoonanan, Sajad J Khazal, Hisham Abdel-Azim, et al.
Blood|October 8, 2025
Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell TransplantationBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.
Transplantation and Cellular Therapy|October 1, 2025
Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study CohortBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.
Pageof 23